Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KCTD3 deficiency disrupts axon initial segment organization and neurite outgrowth in a neurodevelopmental disorder mouse model.

Communications biology·2026
Same author

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same author

A multiplexed targeted mass spectrometric assay for quantifying obesity- associated biomarkers in human plasma.

Research square·2026
Same author

Assessing current capabilities for incorporating lipidomics in multiomics data integration.

Briefings in bioinformatics·2026
Same author

Probiotic Bifidobacterium bifidum BGN4 supplementation modulates gut microbiome composition and reduces circulating zonulin, TNFα, and insulin in adults with excess adiposity: a randomized, double-blind, placebo-controlled trial.

Nutrition & metabolism·2026
Same author

Molecular pathways for learning in the single-cell Stentor coeruleus.

Current biology : CB·2026

Related Experiment Video

Updated: Jun 20, 2025

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.1K

Multiplexed quantitative proteomics in prostate cancer biomarker development.

Yuqian Gao1, Hyeyoon Kim1, Reta Birhanu Kitata1

  • 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.

Advances in Cancer Research
|July 20, 2024
PubMed
Summary
This summary is machine-generated.

New proteomics technologies improve prostate cancer (PCa) detection beyond prostate-specific antigen (PSA). These advanced methods identify aggressive PCa and reduce overtreatment by analyzing diverse samples for novel protein biomarkers.

Keywords:
DIAEarly detectionPRMProstate cancerProtein biomarkerRisk stratificationSRM

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Related Experiment Videos

Last Updated: Jun 20, 2025

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.1K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Area of Science:

  • Oncology
  • Proteomics
  • Biomarker Discovery

Background:

  • Prostate cancer (PCa) is a leading cancer in US men.
  • Current biomarkers like prostate-specific antigen (PSA) have limitations in detecting aggressive disease and can lead to overtreatment.
  • There is a critical need for improved protein biomarkers for accurate PCa diagnosis and management.

Purpose of the Study:

  • To provide an overview of state-of-the-art proteomics technologies for prostate cancer (PCa) biomarker development.
  • To review methods for enhancing protein detection sensitivity and enriching specific molecular information.
  • To summarize recent validation studies of novel PCa protein biomarkers.

Main Methods:

  • Liquid chromatography-mass spectrometry (LC-MS)-based proteomics.
  • Protein/peptide enrichment strategies (antibody-based and independent) for low-abundance proteins.
  • Enrichment of post-translational modifications (e.g., glycosylation) and extracellular vesicles.
  • Advanced data acquisition methodologies for increased accuracy and throughput.

Main Results:

  • Demonstrated advancements in detecting low-abundance proteins and specific modifications.
  • Successful application of proteomics techniques across diverse specimen types (cell lines, tissues, biofluids, blood).
  • Development of novel protein biomarkers for various clinical applications in PCa.

Conclusions:

  • Advanced proteomics technologies offer significant potential for improving prostate cancer (PCa) biomarker discovery.
  • These methods enhance sensitivity and specificity, enabling better detection of aggressive PCa.
  • Novel protein biomarkers developed through these techniques can aid in early diagnosis, prognosis, and therapeutic intervention.